MedTrace Logo

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures

NCT02269397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 371

Last updated 2019-07-31

No results posted yet for this study

Summary

The primary goal of this observational study is to establish the accuracy of CNS-specific Assay for Recurrent Paroxysmal Events (CARPE) as a diagnostic blood test for epilepsy. The target population is patients who have been newly referred to the Penn Epilepsy Center or patients who are admitted to HUP for continuous video EEG monitoring. (Subjects without an epilepsy diagnosis will be included.) Subjects will be asked to provide consent, agree to allow the study team to collect information from their medical record, and to provide at least one blood sample.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Peter Crino, MD, PhD · Cognizance Biomarkers, LLC

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-07-14
Completion
2018-12-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02269397 on ClinicalTrials.gov